COMMUNIQUÉS West-GlobeNewswire

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
03/06/2024
Data from 13 participants presented at the American Transplant Congress continue to support safety and tolerability profile of tegoprubart Overall mean eGFR of all reported time points after day 30 post-transplant of 70 [...]
HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
03/06/2024
Highlights of the first quarter include: Revenue of $287.6 million, an increase of 18% compared to $244.4 million in Q1 FY24. Net income of $28.8 million, compared to $4.1 million in Q1 FY24, with non-GAAP net income of [...]
Invivyd to Participate at the Jefferies Global Healthcare Conference
03/06/2024
WALTHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that its management [...]
Celcuity To Participate in Jefferies Global Healthcare Conference
03/06/2024
MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the [...]
BridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia on June 4, 2024
03/06/2024
PALO ALTO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of its [...]
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
03/06/2024
- 40% of efficacy-evaluable patients (2 out of 5) in the initial cohort of patients with anti-PD-1 refractory melanoma treated with TransCon IL-2 β/γ in combination with TransCon TLR7/8 Agonist exhibited confirmed [...]
CloudMD Announces Filing and Mailing of the Management Information Circular in Connection with the Proposed Go-Private Transaction with CPS Capital
03/06/2024
Your vote is important no matter how many shares you hold. The Board of Directors of CloudMD unanimously recommends that Securityholders vote IN FAVOUR of the Arrangement Resolution. Questions or requests for voting [...]
BlueSphere Bio Announces IND Clearance of its First in Human Candidate and New Cell Therapy Portfolio for High-Risk Leukemia Patients
03/06/2024
TCX-101 Clinical Program : TCR T-Cell therapy product candidate (BSB-1001) to be delivered simultaneously with allogeneic stem cell transplant in patients with active disease or high risk of relapse First patient to be [...]
Oxford Treatment Center Launches The Rally Point: Valkyrie Program, a Specialty Program for Female Veterans
03/06/2024
OXFORD, Miss., June 03, 2024 (GLOBE NEWSWIRE) -- Oxford Treatment Center has launched a new specialized treatment program specifically tailored for female Veterans. The Rally Point: Valkyrie Program draws inspiration [...]
Public Hearings on Protecting and Improving Local Hospitals: Community members invited to give input
03/06/2024
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- In response to more than 1,200 closures of emergency departments and other local hospital services over the last year, the Ontario Health Coalition (OHC) is holding public [...]
Late-breaking results from PALOMA-2 study of subcutaneous RYBREVANT®▼ (amivantamab) in combination with lazertinib show clinically meaningful antitumour response and improved safety profile in patients with EGFR-mutated non-small cell lung cancer
03/06/2024
Significantly lower infusion-related reactions seen with subcutaneous amivantamab compared with intravenous administration in new Phase 2 data 1 BEERSE, BELGIUM, June 03, 2024 (GLOBE NEWSWIRE) -- Janssen-Cilag [...]
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting
03/06/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length [...]
L’anticorps MCLA-129 produit par Merus ou la promesse d’une monothérapie efficace dans le traitement du CPNPC présentant une mutation de l’exon 14 du gène MET - une présentation sous forme de poster est prévue lors du congrès annuel 2024 de l’ASCO®
03/06/2024
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 03 juin 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus, la Société, nous, ou notre », une société spécialisée dans l’oncologie au stade [...]
NADP Push for Greater Access to Dental Benefits Gaining Traction in Congress
03/06/2024
CBO estimates Independent Purchase of Dental Plans Would Reduce Deficit DALLAS, June 03, 2024 (GLOBE NEWSWIRE) -- After the National Association of Dental Plans (NADP) advocated for the passage of the Increasing Access [...]
Conor McGregor and Virat Kohli Collaborate to Launch TIDL's Innovative Pain Relief Products in India
03/06/2024
TIDL’s Game-Changing Products Now Rolling Out to 40,000 Stores Across India LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- TIDL, the fastest-growing pain relief brand in the United States , is thrilled to announce its [...]
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
03/06/2024
Company reaffirms commitment to maintaining appropriate standards of animal welfare WEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV), a leading [...]
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
03/06/2024
HOUSTON, June 03, 2024 (GLOBE NEWSWIRE) -- 7 Hills Pharma Inc. (“7 Hills” or “7HP”), a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, [...]
Oswego Health Partners with Wellthy to Deliver Comprehensive Caregiving Support to Employees and their Families
03/06/2024
Oswego Health becomes the largest healthcare employer in Central New York to partner with Wellthy to support employee caregivers New York, NY, June 03, 2024 (GLOBE NEWSWIRE) -- Oswego Health – the Central New York [...]
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
03/06/2024
HINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company’s common [...]

Pages